American Pathologists Meeting

Is Sentinel Lymph Node Biopsy Truly the Standard of Care in Melanoma?

Rosemary Frei, MSc

December 2011, Vol 2, No 7 - American Pathologists Meeting

Grapevine, TX—Two expert oncologists presented the clinical data in support for and against the use of sentinel lymph node biopsy (SLNB) in melanoma as the standard of care during the 2011 College of American Pathologists annual meeting.

Vernon Sondak, MD, Chair, De - partment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, supported the use of SLNB as the standard of care in melanoma.

J. Meirion Thomas, MD, attending oncologist, Royal Marsden Hospital and Imperial College, London, said that routine SLNB in melanoma is unwarranted.
[ Read More ]